Yao-Yao Zhu

Company: AstraZeneca

Job title: Director, Global Regulatory Affairs

Seminars:

Exploring the Development of Novel Endpoints & Negotiating Endpoint Approval with Regulatory Bodies 1:15 pm

Examining how endpoints are determined by considering starting points, planning, and use of biomarkers Discussing the iterative process that must be done to validate the endpoints Sharing advice on negotiations with regulatory bodies to facilitate more efficient conversationsRead more

day: Conference Day One